Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Prebiotic Fiber
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Daacro
Deal Size : Inapplicable
Deal Type : Inapplicable
Chicory Root Prebiotic Effects On Mood and Stress In Healthy Adults
Details : Prebiotic Fiber is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Stress Disorders, Traumatic.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
July 10, 2025
Lead Product(s) : Prebiotic Fiber
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Daacro
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Low Glycaemic Index
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : German Sport University, Cologne
Deal Size : Inapplicable
Deal Type : Inapplicable
Investigating the Effects of Diet and Physical Activity on Esport Performance
Details : Low Glycaemic Index is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
May 30, 2023
Lead Product(s) : Low Glycaemic Index
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : German Sport University, Cologne
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : New Prebiotic Follow-On Formula
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Universitair Ziekenhuis Brussel
Deal Size : Inapplicable
Deal Type : Inapplicable
Prebiotic Effects in Healthy Toddlers
Details : New Prebiotic Follow-On Formula is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
March 24, 2023
Lead Product(s) : New Prebiotic Follow-On Formula
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Universitair Ziekenhuis Brussel
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Isomaltulose
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Swansea University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Isomaltulose is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
August 29, 2022
Lead Product(s) : Isomaltulose
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Swansea University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Prebiotic
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : University of Reading
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Prebiotics on Intestinal Colonization and Mood in a University Cohort
Details : Prebiotic is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
January 28, 2022
Lead Product(s) : Prebiotic
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : University of Reading
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Prebiotic
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Prebiotic is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
March 10, 2021
Lead Product(s) : Prebiotic
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitalose
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : BioTeSys GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Investigation of Blood Glucose and Insulin Response After Intake of Vitalose
Details : Vitalose is a drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 22, 2020
Lead Product(s) : Vitalose
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : BioTeSys GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable